Format

Send to

Choose Destination
See comment in PubMed Commons below
Urologe A. 2013 Oct;52(10):1459-68; quiz 1467-8. doi: 10.1007/s00120-013-3284-4.

[Infection and sepsis prevention in prostate biopsy].

[Article in German]

Author information

1
Klinik für Urologie, Kinderurologie und Andrologie, Universitätsklinikum Giessen und Marburg GmbH, Standort Giessen, Justus-Liebig-Universität, Rudolf-Buchheim-Str. 7, 35392, Giessen, Deutschland, Wagenlehner@AOL.com.

Abstract

Prostate biopsy is currently the gold standard in the diagnosis of carcinoma of the prostate. An estimated one million prostate biopsies are performed every year in Europe. Worldwide the most frequent form is the transrectal prostate biopsy using preoperative fluoroquinolone prophylaxis. In recent years an increasing rate of infectious complications after prostate biopsy has been observed. The main causative factor is fecal fluoroquinolone-resistant bacteria. This review aims to present the current evidence regarding infectious complications after prostate biopsy and strategies to reduce symptomatic infections and urosepsis.

PMID:
24026889
DOI:
10.1007/s00120-013-3284-4
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center